Prostanoids play an important role in the regulation of parturition. All reproductive tissues, including fetal membranes, decidua, and myometrium, have the capacity to synthesize prostanoids, and fetal membranes have been shown to express elevated levels of cyclooxygenase-2 (Cox-2) at the onset of labor. We have now investigated the expression of Cox-2 in human myometrium. Myometrial samples collected from women in labor during lower segment cesarean section expressed 15-fold higher levels of Cox-2 messenger ribonucleic acid (mRNA) compared to myometrial specimens collected from women not in labor, as detected by Northern blot analysis. Immunohistochemical detection of Cox-2 protein showed cytoplasmic staining in the smooth muscle cells of the myometrium. Cultured myometrial cells expressed low levels of Cox-2 mRNA under baseline conditions, but interleukin-1␤ (IL-1␤) caused a 17-fold induction of expression of the Cox-2 transcript after incubation for 6 h. IL-1␤ also induced expression of biologically active Cox-2 protein, as detected by immunofluorescence, Western blot analysis, and measuring the conversion of arachidonic acid to prostanoids in the presence and absence of a Cox-2-selective inhibitor, NS-398. PGE 2 receptor subtype EP 2 mRNA was expressed in cultured myometrial smooth muscle cells, whereas transcripts for EP 1 , EP 3 , EP 4 , FP, and IP were low or below the detection limit as measured by Northern blot analysis. However, IL-1␤ stimulated expression of EP 4 receptor mRNA. Our data suggest that expression of Cox-2 transcript is elevated at the onset of labor in myometrial smooth muscle cells, which may depend on induction by cytokines. As, in addition to Cox-2, the expression of prostanoid receptors is regulated, not only the production of prostanoids, but also responsiveness to them, may be modulated. (J Clin Endocrinol Metab 85: 3468 -3475, 2000) 
the Cox-2 transcript after incubation for 6 h. IL-1␤ also induced expression of biologically active Cox-2 protein, as detected by immunofluorescence, Western blot analysis, and measuring the conversion of arachidonic acid to prostanoids in the presence and absence of a Cox-2-selective inhibitor, NS-398. PGE 2 receptor subtype EP 2 mRNA was expressed in cultured myometrial smooth muscle cells, whereas transcripts for EP 1 , EP 3 , EP 4 , FP, and IP were low or below the detection limit as measured by Northern blot analysis. However, IL-1␤ stimulated expression of EP 4 receptor mRNA. Our data suggest that expression of Cox-2 transcript is elevated at the onset of labor in myometrial smooth muscle cells, which may depend on induction by cytokines. As, in addition to Cox-2, the expression of prostanoid receptors is regulated, not only the production of prostanoids, but also responsiveness to them, may be modulated. (J Clin Endocrinol Metab 85: 3468 -3475, 2000) P ROSTANOIDS play an important role in the regulation of parturition (1) (2) (3) . Two cyclooxygenase (Cox) genes have been cloned (Cox-1 and Cox-2), which are the ratelimiting enzymes in the conversion of arachidonic acid to prostanoids (4, 5) . Although Cox-1 is constitutively expressed, levels of Cox-2 are low or undetectable at basal conditions in most tissues, but the expression of Cox-2 can be induced by proinflammatory cytokines, tumor promoters, and hormones. Recent knockout studies suggest that although Cox-2 is important in reproductive functions such as ovulation, fertilization, implantation, and decidualization (6, 7) , Cox-1 controls the onset of labor by inducing luteolysis (8) . Whether these observations are applicable to humans is not known. Indeed, in women, expression of Cox-2, rather than Cox-1, is elevated at the onset of labor in fetal membranes (9 -14) . Furthermore, it was recently suggested that a Cox-2 preferential (but not selective) inhibitor may be effective in preventing premature birth (15) , but it is not clear whether this approach is safe for the neonatal kidneys (16) . In cell culture conditions proinflammatory cytokines, such as interleukin-1␤ (IL-1␤) and tumor necrosis factor-␣ (TNF␣), induce the expression of Cox-2 in amnion-derived WISH cells and in cells derived from chorion and decidua (17) (18) (19) (20) . In addition, IL-1␤ and TNF␣ stimulate the synthesis of prostanoids in myometrial cells (21) , which is at least partially mediated by increased activity of phospholipase A 2 (22) . However, in contrast to fetal membranes, myometrial Cox-2 expression was not increased at the onset of labor (23) (24) (25) (26) .
Prostanoids transduce their signals via seven transmembrane receptors that couple to different guanine nucleotidebinding (G) proteins and downstream signal transduction systems (27) . Knockout studies indicate that the PGE 2 receptor subtype EP 2 is involved with ovulation and/or fertilization (28, 29) , and the receptor for PGF 2␣ is important at the onset of labor by inducing luteolysis in mice (30) . In the uterus PGF 2␣ facilitates contractile signals via PGF 2␣ receptor (FP receptor), whereas PGE 2 can either contract via EP 1 and EP 3 receptors or relax via EP 2 and EP 4 receptors (31, 32) . Interestingly, the expression pattern of prostanoid receptors changes during pregnancy and at the onset of labor in human myometrium (33, 34) . However, very little is known about the factors that regulate the expression of prostanoid receptors.
The purpose of this study was to investigate the expression of Cox-2 in human lower segment myometrium obtained from women in labor and those not in labor. We also exam-ined the effect of proinflammatory cytokines on the expression of Cox-2 messenger ribonucleic acid (mRNA) and protein and on the expression of EP [1] [2] [3] [4] , FP, and prostacyclin receptor (IP receptor) transcripts in cultured myometrial smooth muscle cells.
Materials and Methods

Patient samples
Myometrial tissues were collected from 25 healthy women at gestation weeks 37-42. Ten women had been in labor for 6 -22 h (mean Ϯ sem, 14.3 Ϯ 1.9 h), their cervix had been opened (6.6 Ϯ 0.9 cm, except patient 4 whose cervix was closed), and 4 -24 h (12.9 Ϯ 2.1) had elapsed from the rupture of fetal membranes. All women in labor had received oxytocin treatment. Fifteen women underwent elective cesarean sections; they did not have regular contractions, and their fetal membranes were intact. Myometrial specimens (ϳ1 cm 3 ) were collected from the upper edge of the uterine incision during lower segment cesarean section with the approval of the local ethics committee. Informed consent was obtained from all patients. Samples were first rinsed in Dulbecco's phosphate-buffered saline (PBS; HyClone Laboratories, Inc., Cramlington, UK), and then endometrial tissue was removed, after which the myometrium was either processed for the tissue culture (see below) or snap-frozen in liquid nitrogen and stored at Ϫ70°C until analyzed. In addition, specimens of lower segment myometrium were collected from patients in labor for immunohistochemical analysis (see below).
Myometrial cell cultures
Myometrial cells were isolated from tissues obtained from either lower segment elective cesarean sections at term (three separate cell lines) or from the fundal part of the uterus of a nonpregnant patient (age, 40 yr) undergoing hysterectomy for myomatous uterus. The specimens were first dissected into small pieces and then digested with freshly prepared collagenase (0.2%; type IV; Sigma, St. Louis, MO) and trypsin (0.05%, Life Technologies, Inc., Paisley, Scotland) in DMEM supplemented with 20 mmol/L HEPES (Life Technologies, Inc.), 2 mmol/L l-glutamine, and antibiotics for 2 h in 37°C at 5% CO 2 in air. Then the suspension was centrifuged, washed once with culture medium, and resuspended in the culture medium, which contained DMEM supplemented with l-glutamine, antibiotics, and 10% FCS (HyClone Laboratories, Inc.). Primary cultures were grown in 75-cm 2 tissue culture flasks (Nunc, Roskilde, Denmark). The cells were used at passages 2-7, and they exhibited positive staining for human smooth muscle actin as detected by immunofluorescence (see below). Before each experiment the confluent cultures were starved for 48 h in DMEM supplemented with 0.5% FCS, and treated with or without IL-1␤ (0.01-10 ng/mL), TNF␣ (100 ng/mL; R&D Systems, Minneapolis, MN), phorbol 12-myristate 13-acetate (PMA; 10 ng/mL; Sigma), oxytocin (0.4 nmol/L; ICN Biomedicals, Inc., Aurora, OH), dexamethasone (1 mol/L; Sigma), NS-398 (15 mol/L; Cayman Chemical Co., Ann Arbor, MI), and/or indomethacin (10 mol/L; Sigma) in 10-cm tissue culture dishes (Nunc) for 2-48 h.
RNA isolation and Northern blot analyses
Total RNA from tissue samples was extracted using the guanidine isothiocyanate-cesium chloride method (35) and from cultured myometrial cells with TRIzol reagent (Life Technologies, Inc.). For Northern blot analysis, 20 g RNA were denatured in 1 mol/L glyoxal, 50% dimethylsulfoxide, and 10 mmol/L phosphate buffer at 50°C for 60 min, and then electrophoresed through 1.2% agarose gel. The RNA was transferred to nylon membranes (Micron Separation, Inc., Westborough, MA). Blots were baked for 1 h at 80°C and cross-linked under UV light for 6 min (Reprostar II UV, Camag, Muttenz, Switzerland). Complementary DNAs (cDNAs) from human open reading frame of EP 1 , EP 3 , EP 4 , FP, and IP receptors were gifts from Merck Frosst Canada, Inc. (Québec, Canada), and the cDNA for human EP 2 receptor open reading frame was a gift from Dr. John W. Regan, University of Arizona (Tucson, AZ). Prostanoid receptor cDNAs, human Cox-2 cDNA, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA (36) were labeled using [␣-
32 P]deoxy-CTP (DuPont-NEN Life Science Products, Boston, MA) and Prime-a-Gene kit (Promega Corp., Madison, WI). Probes were purified with nick columns (Pharmacia, Uppsala, Sweden) and used at 1 ϫ 10 6 cpm/mL. Hybridizations were performed at 42°C for 16 h in solution containing 50% formamide, 6 ϫ SSC (standard saline citrate), 0.1% Ficoll, 0.1% polyvinylpyrrolidone, 0.1% BSA, 100 g/mL herring sperm DNA, 100 g/mL yeast RNA, and 0.5% SDS. Membranes were washed three times at 50°C for 15 min each time in 0.1 ϫ SSC and 0.1% SDS. Northern blots were visualized by autoradiography and were quantitated using NIH Image 1.57 on a Macintosh personal computer.
Immunofluorescence
For immunofluorescence, myometrial cells were grown on chamber slides (Nunc) and then treated with or without IL-1␤ (10 ng/mL) or PMA (10 ng/mL) for 6 h. The cells were fixed with ice-cold acetone for 5 min, and then the chambers were washed three times with PBS for 10 min each time at room temperature. Nonspecific binding of antibodies was blocked with 1% BSA in PBS for 15 min. The samples were then incubated with a 1:40 dilution of antihuman Cox-2 polyclonal antibodies (Cayman Chemical) at room temperature for 30 min and washed with 1% BSA in PBS three times for 10 min. The secondary antibody (1:50 dilution), fluorescein isothiocyanate-conjugated goat antirabbit IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA), was added and incubated for 30 min, and the samples were then washed with 1% BSA in PBS three times for 10 min each time. Normal rabbit IgG (30 g/mL; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was used as a control. Monoclonal antihuman smooth muscle actin antibody (1:50; DAKO Corp., Klostrup, Denmark) and fluorescein isothiocyanateconjugated rabbit antimouse Ig (1:40, DAKO Corp.) were used to confirm the purity of the myometrial smooth muscle cell cultures.
Western blotting
Myometrial cells were treated with or without IL-1␤ or PMA for 6 h, after which they were lysed in RIPA buffer (150 mmol/L NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS, 50 mmol/L Tris, and 1 mmol/L ethylenediamine tetraacetate, pH 8.0), supplemented with protease inhibitors aprotinin (1 g/mL) and phenylmethylsulfonylfluoride (100 g/mL), and centrifuged at 15,000 ϫ g for 20 min. Protein concentration was measured with a BSA protein assay (Pierce Chemical Co., Rockford, IL). Proteins (100 g) were resuspended in sample loading buffer [110 mmol/L Tris-HCl (pH 6.8), 2% SDS, 9% glycerol, 5% ␤-mercaptoethanol, and 0.005% bromophenol blue] and separated by SDS (12%)-PAGE. The proteins were transferred electrophoretically to Hybond-C extra nitrocellulose membranes (Amersham Pharmacia Biotech, Aylesbury, UK). Nonspecific binding was blocked by Tris-buffered saline/Nonidet P40 (TBS-NP40)/5% low fat dry milk solution overnight at 4°C. For immunodetection, membrane was incubated with antimouse Cox-2 polyclonal IgG (1:1,000 dilution; Cayman Chemical) for 1 h at room temperature. The membrane was washed three times in TBS-NP40, and incubated with goat antirabbit antibodies conjugated to horseradish peroxidase (1:2,000 dilution) for 1 h at room temperature. After four washes with TBS-NP40, Cox-2 proteins were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech).
Immunohistochemistry
Formalin-fixed and paraffin-embedded specimens were sectioned (4 -5 m), deparaffinized, and microwaved for 2.5 min at 800 watts and for 15 min at 440 watts in 0.01 mol/L sodium citrate buffer (pH 6.0). The slides were immersed in 0.6% hydrogen peroxide in methanol for 30 min and then in blocking solution (0.01 mol/L Tris, 0.1 mol/L MgCl 2 , 0.5% Tween-20, 1% BSA, and 5% normal goat serum) for 1 h to block endogenous peroxidase activity and unspecific binding sites, respectively. Immunostaining was performed with an affinity-purified antimouse Cox-2 polyclonal antibody (Cayman Chemical) in a dilution of 1:250 in the blocking solution at 4°C overnight. The sections were thereafter treated with biotinylated secondary antirabbit antibodies in a dilution of 1:200 (Vectastain ABC kit, Vector Laboratories, Inc., Burlingame, CA), and antibody-binding sites were finally visualized by avidin-biotin peroxidase complex solution (ABComplex, Vectastain, Vector Laboratories, Inc.) and 3-amino-9-ethylcarbazole (Lab Vision Co., Fremont, CA). The counterstaining was performed with Mayer's hemalum (Merck & Co., Darmstadt, Germany). Specificity was determined by preadsorption of the anti-Cox-2 antibodies using a Cox-2 control peptide (20 g/mL; Cayman Chemical). Monoclonal antihuman smooth muscle actin antibody (1:1000) and rabbit antimouse immunoglobulin (1:200; Vector Laboratories, Inc.) were used for identification of the smooth muscle cells.
Assays for measuring the release of prostanoids from cultured myometrial cells
Myometrial cells were first incubated with the test agents for 6 h, after which the cells were washed once with PBS and incubated further with arachidonic acid (10 mol/L; Sigma) for 10 min. PGE 2 and PGF 2␣ were analyzed by enzyme immunoassay (Cayman Chemical). 6-Keto PGF 1␣ , a stable hydrolysis product of prostacyclin (PGI 2 ), was analyzed with RIA employing specific antibodies (37) and a tritiated 6-keto-PGF 1␣ (Amersham Pharmacia Biotech). The intra-and interassay coefficients of variation were 8% and 14% (n ϭ 10), respectively. Recovery of 6-keto-PGF 1␣ added to culture medium was 92 Ϯ 12% (mean Ϯ sd; n ϭ 10). Parallelism of two dilutions of the unknown and the standard curve was a prerequisite for acceptance of the assay.
Statistical analysis
The statistical significance of cell culture experiments was calculated for a single comparison using Student's t test. For multiple comparison, the t test was used only if one-way ANOVA indicated a significant difference. Mann-Whitney U test was used to test for significant differences between the not in labor group and the in labor group. The Spearman correlation was used for calculating the significance of the correlation. All results are shown as the mean Ϯ sem, and P Ͻ 0.05 was selected as the statistically significant value.
Results
Expression of Cox-2 mRNA was compared in human lower segment myometrium obtained from women who were or were not in labor. Myometrial samples collected from women in labor expressed elevated levels of Cox-2 mRNA (15.2 Ϯ 3.5-fold; P Ͻ 0.0001) compared to myometrial specimens collected from women not in labor, as detected by Northern blot analysis (Fig. 1) . Expression of Cox-2 mRNA was not associated with the time from the beginning of regular contractions or the rupture of fetal membranes (not shown). Immunohistochemical detection of Cox-2 protein showed cytoplasmic staining in the smooth muscle cells of the myometrium (Fig. 2) . Interestingly, there was little Cox-2 staining in the smooth muscle cells of the veins, as shown in Fig. 2 .
Cultured human myometrial cells that originated from lower segment cesarean sections expressed low levels of Cox-2 mRNA under baseline conditions, but the expression was induced by IL-1␤ in concentration-and time-dependent manner (Fig. 3) . The peak induction was obtained after incubation with IL-1␤ (10 ng/mL) for 6 h (Fig. 3A) , at which time Cox-2 mRNA expression was stimulated by 17.1 Ϯ 1.5-fold (P Ͻ 0.0001), as detected in three different myometrial cell lines, each tested in four separate experiments (n ϭ 12). Expression of Cox-2 transcript was also induced by TNF␣ and PMA, but not by oxytocin (Fig. 4A ). An identical pattern of induction of Cox-2 mRNA was also found in myometrial cell cultures isolated from fundal part of the uterus from a nonpregnant patient (Fig. 4A) . The effect of IL-1␤ on Cox-2 mRNA expression was blocked by dexamethasone, but not by a Cox-2-selective inhibitor NS-398 (Fig. 4B) .
IL-1␤ and PMA also induced expression of Cox-2 protein, as detected by immunofluorescence staining and Western blot analysis (Fig. 5) . To investigate whether IL-1␤ induced expression of enzymatically active Cox-2 protein, the cells were treated with IL-1␤ for 6 h, after which they were further incubated in the presence of arachidonic acid (10 mol/L) for 10 min. Cox-2 converted arachidonic acid mainly to 6-keto-PGF 1␣ and also to PGE 2 and PGF 2␣ (Fig. 6A) , which is consistent with previously published data (21, 38, 39) . Preincubation with IL-1␤ (10 ng/mL) for 6 h stimulated the release of 6-keto-PGF 1␣ by 9.1 Ϯ 1.3-fold (P Ͻ 0.0001), as detected in four separate experiments (n ϭ 16). Consistent with our mRNA data, TNF-␣, but not oxytocin, also induced the conversion of arachidonic acid to 6-keto-PGF 1␣ (Fig. 6B) . IL-1␤-induced conversion of arachidonic acid to 6-keto-PGF 1␣ was blocked by the Cox-2-selective inhibitor NS-398, whereas the nonselective inhibitor indomethacin also suppressed the basal, presumably Cox-1-dependent, release of 6-keto-FIG. 1. Expression of Cox-2 mRNA in the lower segment human myometrium at term. Myometrial tissues were collected from elective cesarean sections (A; not in labor; n ϭ 15) or from women who were in labor (B; n ϭ 10). Expression of Cox-2 mRNA was detected by Northern blot hybridization, and GAPDH was used as a loading control. C, The results are shown as arbitrary densitometric units (Cox-2/GAPDH; mean Ϯ SEM). The difference between not in labor and in labor groups was statistically significant (P Ͻ 0.0001).
PGF 1␣ (Fig. 6C) . In addition, dexamethasone inhibited IL-1␤-induced conversion of arachidonic acid to 6-keto-PGF 1␣ (not shown).
We also investigated the effect of IL-1␤ and PMA on expression of EP [1] [2] [3] [4] , FP, and IP receptor mRNAs in cultured myometrial cells. The cells expressed a relatively high level of PGE 2 receptor subtype EP 2 mRNA, as detected by Northern blot analysis (Fig. 7) . Basal expression of transcripts for EP 1 receptor mRNA (Fig. 7) . The size of the major human EP 2 receptor transcript is 3.1-3.5 kb (40, 41) , which is consistent with our data. Additional EP 2 receptor messages (2.5 and 4.5 kb) have also been described (41). Our EP 2 probe recognized a message that may correspond to the 4.5-kb mRNA species, but as total RNA was used in the Northern blot assay, we cannot exclude the possibility of cross-hybridization to ribosomal RNA. The size of the EP 4 transcript was approximately 3.8 kb, which is consistent with previously published data (42, 43) .
Discussion
Expression of Cox-2 mRNA was elevated over 15-fold in the myometrium at the onset of term labor. Although Cox-2 mRNA expression levels were clearly increased in most of our in labor specimens, 2 of 10 samples did not express elevated levels of the transcript. We did not, however, find any correlation between the level of Cox-2 expression and cervical dilation, duration of labor, or length of rupture of the membranes. Thus, there may exist biological diversity in the expression pattern of Cox-2 mRNA in women in labor. However, all not in labor specimens contained either low or undetectable levels of the transcript. Previously, Zuo et al. found a decrease in the expression of Cox-2 mRNA using in situ hybridization (23), whereas Moore et al. found no change in Cox-2 mRNA expression using RT-PCR analysis in human myometrium at the onset of labor (24) . Recently, Slater et al. found an increase in Cox-2 mRNA expression before the onset of labor, but not at the onset of labor, by using RT-PCR (25) . These discrepancies may partially depend on the collection of specimens and/or the different methods used. However, our myometrial mRNA data are consistent with previous data obtained by analyzing Cox-2 mRNA in amnion and chorion, although in the fetal membranes expression of Cox-2 is induced only by 2-to 4-fold (10, 11, 13) . Interestingly, it has been previously shown that steady state mRNA levels correlate better with the biologically active Cox-2 protein than does the measurement of immunoreactive Cox-2 protein when comparing in labor vs. not in labor amniotic tissues (9, 10) . Thus, it may well be that neither immunohistochemistry nor immunoblotting is a sufficient measure of biologically active Cox-2 protein in reproductive tissues in vivo. Indeed, previous studies have shown that measurement of Cox-2 protein using immunohistochemistry (23) or immunoblotting (26) is not elevated during labor in myometrial tissues. We used immunohistochemistry to localize Cox-2 protein into the smooth muscle cells of the myometrium. In contrast, no immunoreactivity was found in connective tissue cells or inflammatory cells. Furthermore, we detected only weak positivity in the smooth muscle cells of veins, indicating that myometrial smooth muscle cells possess certain specificity in expressing Cox-2 protein during labor.
IL-1␤ has been shown to stimulate the production of prostanoids in human myometrial cells (21, 44) by activating phospholipase A 2 (22) , and recently, IL-1␤ was also shown to induce Cox-2 expression in an immortalized human myometrial smooth muscle cell line (45) . In our experiments, cultured human myometrial smooth muscle cells expressed low or undetectable levels of Cox-2 mRNA and protein, which both were induced by IL-1␤. IL-1␤-induced steady state levels of the Cox-2 mRNA were elevated by 17-fold during incubation for 6 h, which is a relatively high induction compared to that in fetal membranes or cells derived from them (17, 46, 47) . IL-1␤-induced Cox-2 mRNA expression was evident after incubation for 2 h, reached its maximum by 6 h, and was still present after 48 h. This is consistent with previous data obtained from decidual cells (18) , but is more sustained than that in amniotic cells (17, 46) . Furthermore, a relatively low concentration of IL-1␤ (0.1 ng/mL) gave close to maximal stimulation of Cox-2 mRNA expression in our model, which is consistent with earlier results obtained using amnion-derived WISH cells (46) , but 10-fold lower than that in decidual cells, ECV cells, or human ovarian granulosaluteal cells (18, 36, 48) . The effect of IL-1␤ was not restricted to the lower segment myometrium or pregnancy, as a similar response was obtained using myometrial cells that originated from the fundal part of the nonpregnant uterus. Furthermore, Cox-2 expression was elevated by TNF␣ and PMA in the myometrial cells that originated from either the lower segment or the fundal part of the uterus, as is the case for other pregnancy tissues (19, 49 -52) . Previously, dexamethasone has been shown to both stimulate (53, 54) and inhibit (50, 55) Cox-2 expression in cells derived from the amnion. In cultured myometrial cells, dexamethasone inhibited the effect of IL-1␤ on Cox-2 expression. All this suggests that proinflammatory cytokines can promote sustained and relatively potent induction of Cox-2 expression in human myometrial cells. However, it is still unclear what role cytokineinduced production of prostanoids plays in the lower   FIG. 6 . Effects of cytokines, phorbol ester, oxytocin, and inhibitors on conversion of arachidonic acid to prostanoids in the cultured myometrial cells. A, The cells were treated with or without IL-1␤ (10 ng/mL) for 6 h, washed with PBS, and incubated further with arachidonic acid (10 mol/L) for 10 min. The stable metabolite of PGI 2 (6-keto-PGF 1␣ ) was determined by RIA, and PGE 2 and PGF 2␣ were determined by enzyme immunoassay (n ϭ 3; mean Ϯ SEM). B, IL-1␤ (10 ng/mL), TNF-␣ (100 ng/mL), and oxytocin (OT; 0.4 nmol/L) were incubated for 6 h, after which the conversion of arachidonic acid to 6-keto-PGF 1␣ was measured. The results are shown as the mean Ϯ SEM for three separate experiments (n ϭ 8). C, The effects of indomethacin (10 mol/L) and NS-398 (15 mol/L) on IL-1␤-induced conversion of arachidonic acid to 6-keto-PGF 1␣ . The results are shown as the mean Ϯ SEM from three separate experiments (n ϭ 9). Asterisks indicate significant (P Ͻ 0.05) differences compared to the untreated cultures (Ctr).
FIG. 7.
Expression of prostanoid receptor mRNAs in the cultured myometrial cells. The cells were treated with IL-1␤ (10 ng/mL) or PMA (10 ng/mL) for 6 h. The expression of EP 2 (major band depicted with an arrow) and EP 4 receptor mRNAs was detected by Northern blot analysis. Cox-2 was used as a positive control, and GAPDH served as the loading control. segment myometrium. The major prostanoid produced by these cells is PGI 2 (Refs. 21, 38, and 39 and the present work), which has been shown to relax the myometrium (31, 56) . Deletion of PGI 2 receptor leads to increased thrombosis and suppression of the inflammatory response in mice (57) . Thus, PGI 2 could potentially reduce the contractile activity of the lower segment, induce vasodilatation, and prevent thromboembolic complications in the uteroplacental circulation (58) . However, it is tempting to speculate that PGI 2 might promote inflammation at the onset of labor and thus promote parturition. It was recently reported that high doses of oxytocin (100 nmol/L) induce 3-to 4-fold induction of expression of Cox-2 protein in human myometrial cells (59) . In our experiments oxytocin (0.4 nmol/L) did not induce the expression of Cox-2 mRNA or stimulate the conversion of arachidonic acid to prostanoids. This indicates that, although patients in our in labor group received oxytocin infusion, oxytocin alone cannot explain the 15-fold elevation of Cox-2 mRNA steady state levels at the onset of labor. We cannot, however, exclude the possibility that oxytocin contributes to the induction in an indirect manner by inducing the release of cytokines or by promoting the expression of their receptors.
Our data demonstrate that PGE 2 receptor subtype EP 2 is expressed in unstimulated myometrial cell cultures, and that IL-1␤ induces the expression of EP 4 receptor. Expression of FP and EP receptor transcripts can be induced by IL-1␤ and/or PMA in human ovarian granulosa-luteal cells (48) (our unpublished data), and PMA increases EP 4 receptor mRNA levels in human monocytoid cell lines and in a human B cell line, but down-regulates the message levels in human T cell lines (60) . In our model, PMA did not modulate the expression of the EP 4 transcript. Thus, regulation of prostanoid receptor expression seems to be dependent on the cell type. Previously, expression of myometrial PG receptors has been shown to be dependent on gestational age, and in early human pregnancy the contractile EP 3 and FP receptors are down-regulated (33) , whereas FP receptor expression increases during labor at term (34) . Interestingly, EP 3 receptor is more prominently expressed in the fundal part of the primate uterus, whereas the relaxatory EP 2 and EP 4 receptors dominate in the lower segment (61) . As myometrial cells, in addition to PGI 2 , produce PGE 2 (Refs. 21, 38, and 39 and the present work), this further indicates that prostanoids produced by the lower segment myometrium would rather relax than contract this part of the uterus.
In conclusion, Cox-2 transcript levels are elevated at the onset of human labor in human myometrial smooth muscle cells. This increase in Cox-2 expression may depend on cytokines released during parturition. Finally, as expression of prostanoid receptors is also regulated in these cells, not only the production of prostanoids but also responsiveness to them, may be modulated.
